Imaging Technique May Show Alzheimer's Progression
CAMBRIDGE, Mass., Aug. 11 -- A team of scientists at the Harvard Institutes of Medicine is working to develop a non-invasive method to image plaque deposits in the brains of patients with Alzheimer's disease as the disease progresses. To date, the only definitive means of diagnosing both the plaque formation and the disease itself has been a posthumous examination of the patient's brain. The Harvard studies were described in the July 29 issue of the
Journal of Medicinal Chemistry.
The technique involves coupling an isotope of the element technetium to large organic molecules that are known to have an affinity for the type of amyloid present in the brain of a patient with Alzheimer's disease. The imaging is then done with single-photon computed tomography, which detects gamma particles emitted by the trace amounts of radioactive technetium probe. Laboratory studies are in progress.
LATEST NEWS
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024
- One-Step Hologram Generation Speeds 3D Display Creation
Apr 24, 2024
- Innovation Award Winners for Laser Technology Honored in Aachen
Apr 23, 2024
- Intech 2024: AI Arrives on the Shop Floor
Apr 22, 2024